China Biologic Products Holdings, Inc. (CBPO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
18TH FL, JIALONG INTERNATIONALBUILDING BEIJING, 100125 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2017 MRQ | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 183,766 | 182,970 | 80,820 | 144,138 | 129,609 | |||
| Cash and cash equivalents | 183,766 | 144,938 | 80,820 | 144,138 | 129,609 | |||
| Short-term investments | 38,033 | |||||||
| Restricted cash and investments | 63,678 | |||||||
| Receivables | 33,919 | 25,145 | 19,403 | 17,270 | 11,206 | |||
| Inventory, net of allowances, customer advances and progress billings | 156,413 | 126,395 | 101,305 | 88,635 | 75,679 | |||
| Inventory | 156,413 | 126,395 | 101,305 | 88,635 | 75,679 | |||
| Prepaid expense | 7,641 | ✕ | ||||||
| Deposits current assets | 1,000 | 10,056 | ||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 5,665 | ||
| Deferred tax assets | 3,954 | 3,225 | 3,346 | 2,065 | 1,841 | |||
| Other undisclosed current assets | 14,321 | 21,321 | 11,436 | 4,543 | (1,841) | |||
| Total current assets: | 393,372 | 369,113 | 279,987 | 264,293 | 222,160 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 132,092 | 105,364 | 80,231 | 73,149 | 51,325 | |||
| Long-term investments and receivables | 53,860 | 48,552 | 18,222 | 11,350 | 10,537 | |||
| Long-term investments | 10,615 | 8,718 | 18,222 | 11,350 | 10,537 | |||
| Accounts and financing receivable, after allowance for credit loss | 43,245 | 39,834 | ||||||
| Intangible assets, net (including goodwill) | 2,585 | 3,542 | ||||||
| Intangible assets, net (excluding goodwill) | 2,585 | 3,542 | ||||||
| Deposits noncurrent assets | 12,792 | 13,667 | 14,753 | |||||
| Restricted cash and investments | 40,230 | 30,524 | 2,912 | |||||
| Other noncurrent assets | 2,244 | 4,861 | 3,475 | ✕ | ||||
| Deferred tax assets, net | 672 | |||||||
| Other undisclosed noncurrent assets | 22,718 | 23,576 | 11,909 | 8,213 | 5,819 | |||
| Total noncurrent assets: | 211,585 | 182,354 | 166,860 | 139,488 | 88,887 | |||
| TOTAL ASSETS: | 604,958 | 551,466 | 446,847 | 403,781 | 311,047 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 13,643 | 14,193 | 13,086 | 8,648 | 7,422 | |||
| Taxes payable | 7,484 | 4,511 | 8,257 | 4,202 | 4,513 | |||
| Accounts payable | 6,159 | 9,682 | 4,829 | 4,446 | 2,909 | |||
| Debt | 84,203 | 9,822 | 7,935 | |||||
| Due to related parties | 7,207 | 4,082 | ||||||
| Other undisclosed current liabilities | 59,798 | 57,463 | 23,393 | 37,762 | 28,281 | |||
| Total current liabilities: | 73,441 | 71,655 | 120,682 | 63,439 | 47,719 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 40,000 | 30,000 | ||||||
| Long-term debt, excluding current maturities | 40,000 | 30,000 | ||||||
| Liabilities, other than long-term debt | 10,380 | 12,849 | 18,694 | 3,356 | 8,562 | |||
| Deferred revenue and credits | 3,756 | 4,526 | 2,765 | 3,004 | 2,912 | |||
| Deferred tax liabilities, net | 7,790 | (3,016) | 2,653 | |||||
| Other liabilities | 6,624 | 8,323 | 8,138 | 3,369 | 2,997 | |||
| Other undisclosed noncurrent liabilities | (7,790) | 3,016 | (2,653) | |||||
| Total noncurrent liabilities: | 10,380 | 12,849 | 50,904 | 36,373 | 5,909 | |||
| Total liabilities: | 83,821 | 84,505 | 171,585 | 99,812 | 53,628 | |||
| Equity | ||||||||
| Equity, attributable to parent | 462,201 | 382,343 | 212,087 | 237,692 | 195,470 | |||
| Common stock | 3 | 3 | 3 | 3 | 3 | |||
| Treasury stock, value | (56,425) | (56,425) | (76,571) | (29,594) | ||||
| Additional paid in capital | 105,460 | 105,080 | 24,008 | 72,032 | 62,252 | |||
| Accumulated other comprehensive income (loss) | (25,320) | (19) | 19,985 | 21,506 | 14,072 | |||
| Retained earnings | 438,483 | 333,704 | 244,661 | 173,745 | 119,143 | |||
| Equity, attributable to noncontrolling interest | 58,936 | 84,619 | 63,175 | 66,278 | 61,949 | |||
| Total equity: | 521,137 | 466,962 | 275,262 | 303,970 | 257,419 | |||
| TOTAL LIABILITIES AND EQUITY: | 604,958 | 551,466 | 446,847 | 403,781 | 311,047 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 341,169 | 296,458 | 243,252 | 203,357 | 184,813 | ||
| Cost of revenue | (124,034) | (106,483) | (80,025) | (65,484) | (58,836) | ||
| Gross profit: | 217,135 | 189,975 | 163,226 | 137,873 | 125,977 | ||
| Operating expenses | (73,220) | (57,389) | (47,171) | (52,013) | (55,405) | ||
| Other operating income, net | 571 | ||||||
| Other undisclosed operating income (loss) | (4,896) | 1,073 | 3,346 | ||||
| Operating income: | 143,915 | 132,586 | 111,159 | 86,933 | 74,489 | ||
| Nonoperating income | 10,005 | 2,512 | 11,593 | 5,469 | 6,646 | ||
| Investment income, nonoperating | 7,816 | 5,551 | 25,645 | 4,433 | 4,679 | ||
| Interest and debt expense | (254) | (1,727) | (3,698) | (1,135) | (1,270) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 3,698 | 1,135 | 1,270 | ||||
| Income from continuing operations before equity method investments, income taxes: | 153,665 | 133,371 | 122,752 | 92,401 | 81,135 | ||
| Income (loss) from equity method investments | 2,519 | (1,311) | 8,646 | 2,170 | 2,666 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (2,265) | 3,039 | (2,666) | ||||
| Income from continuing operations before income taxes: | 153,919 | 135,098 | 131,398 | 94,572 | 81,135 | ||
| Income tax expense | (25,126) | (20,993) | (26,640) | (15,540) | (15,163) | ||
| Income from continuing operations: | 128,793 | 114,106 | 104,759 | 79,032 | 65,972 | ||
| Income before gain (loss) on sale of properties: | 128,793 | 114,106 | 104,759 | 79,032 | 65,972 | ||
| Other undisclosed net loss | (8,646) | (2,170) | |||||
| Net income: | 128,793 | 114,106 | 96,113 | 76,861 | 65,972 | ||
| Net loss attributable to noncontrolling interest | (24,014) | (25,063) | (25,196) | (22,260) | (20,750) | ||
| Net income attributable to parent: | 104,779 | 89,043 | 70,917 | 54,602 | 45,222 | ||
| Other undisclosed net loss available to common stockholders, basic | (2,987) | (2,071) | (1,211) | (456) | (70) | ||
| Net income available to common stockholders, basic: | 101,792 | 86,972 | 69,706 | 54,145 | 45,153 | ||
| Other undisclosed net loss available to common stockholders, diluted | (1,769) | ||||||
| Net income available to common stockholders, diluted: | 101,792 | 86,972 | 69,706 | 54,145 | 43,383 | ||
Comprehensive Income ($ in thousands)
| 6/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net income: | 128,793 | 114,106 | 96,113 | 76,861 | 65,972 | ||
| Other undisclosed comprehensive income (loss) | (31,303) | (24,368) | (1,919) | 9,126 | 1,735 | ||
| Comprehensive income: | 97,490 | 89,737 | 94,194 | 85,987 | 67,707 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (19,027) | (20,698) | (24,798) | 23,952 | 21,164 | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (47,903) | (42,327) | |||||
| Comprehensive income, net of tax, attributable to parent: | 78,464 | 69,039 | 69,396 | 62,036 | 46,544 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.